The Use of Gene‐Modified Tumor‐Infiltrating Lymphocytes for Cancer Therapy

This publication has 41 references indexed in Scilit:

• The Development of Gene Therapy for the Treatment of Cancer
  Annals of Surgery, 1993
• Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.
  The Journal of Experimental Medicine, 1993
• Comparative Immunohistochemical Study of Four Monoclonal Antibodies Directed Against Ovarian Carcinoma-Associated Antigens
  International Journal of Gynecological Pathology, 1991
• T cell targeting in cancer therapy
  Cancer Immunology, Immunotherapy, 1991
• A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
  Cell, 1990
• Chimeric immunoglobulin-T cell receptor proteins form functional receptors: Implications for T cell receptor complex formation and activation
  Cell, 1990
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regions
  Biochemical and Biophysical Research Communications, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987